Northern Trust’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Northern Trust’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-17,911	Closed	-$652K	–	4308
2016 Q4	$652K	Buy	17,911 +6,864	+62%	+$243K	﹤0.01%	3468
2016 Q3	$421K	Buy	+11,047	New	+$163K	﹤0.01%	3552

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Northern Trust's CLCD Position: Q1 2017 in Review

Northern Trust sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 17,911 shares — an estimated $652K sold.

Northern Trust first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $652K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Northern Trust reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Northern Trust sold 17,911 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $652K.
Northern Trust first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Northern Trust's CoLucid Pharmaceuticals, Inc. position peaked at $652K in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Northern Trust's 13F filing for Q1 2017, filed 12 May 2017.